PHARMACEUTICAL COMPOSITIONS CONTAINING ALENDRONATE FOR TREATING PERIODONTAL DISEASE AND ALVEOLAR BONE LOSS

摘要

The present invention provides a pharmaceutically acceptable salt comprising an effective amount of 4-amino-1-hydroxybutylidene-1,1-bisphosphonic acid or monosodium salt trihydrate (alendronate) of the formula (I) It is characterized by administering, a method for treating a periodontal disease in a mammal, including humans. The compounds are useful for the treatment of alveolar bone loss associated with fasciitis and periodontal disease.